F2 and COVID-19: The study of hemodynamic stability showed that most of the mild and severe COVID-19 patients and control individuals had normal values for prothrombin time (PT; measured in seconds, percentage, or international normalized ratio [INR]) and activated partial thromboplastin time (aPTT; measured in seconds and ratio).